Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID Reference, 4th edition, 372 pages

+ the daily Top 10

  Kidney Transplantation

  Free Subscription

Articles published in Kidney Int

Retrieve available abstracts of 125 articles:
HTML format

Single Articles

    August 2020
  1. BONTHUIS M, Cuperus L, Chesnaye NC, Akman S, et al
    Results in the ESPN/ERA-EDTA Registry suggest disparities in access to kidney transplantation but little variation in graft survival of children across Europe.
    Kidney Int. 2020;98:464-475.
    PubMed     Abstract available

    The meaning of borderline rejection in kidney transplantation.
    Kidney Int. 2020;98:278-280.
    PubMed     Abstract available

  3. COATES PT, Wong G
    The forgotten fallen: painful reality of a pandemic.
    Kidney Int. 2020;98:251-252.

  4. AZIZ F, Muth B, Parajuli S, Garg N, et al
    Unusually high rates of acute rejection during the COVID-19 pandemic: cause for concern?
    Kidney Int. 2020;98:513-514.

    July 2020
  5. HEYBELI C, Bentall A, Wen J, Alexander MP, et al
    A study from The Mayo Clinic evaluated long-term outcomes of kidney transplantation in patients with immunoglobulin light chain amyloidosis.
    Kidney Int. 2020 Jul 23. pii: S0085-2538(20)30830.
    PubMed     Abstract available

  6. KIM J, Perkins GB, Coates PT
    Evolutionary immunology: how your ancestry can affect your kidney transplant.
    Kidney Int. 2020;98:45-47.

    June 2020
  7. LEE J, Huh KH
    Kidney transplantation trends in South Korea during the COVID-19 pandemic.
    Kidney Int. 2020 Jun 19. pii: S0085-2538(20)30692.

  8. FERNANDEZ-RUIZ M, Seron D, Alonso A, Lora D, et al
    Derivation and external validation of the SIMPLICITY Score as a simple immune-based risk score to predict infection in kidney transplant recipients.
    Kidney Int. 2020 Jun 12. pii: S0085-2538(20)30638.
    PubMed     Abstract available

  9. GAUTIER-VARGAS G, Baldacini C, Benotmane I, Keller N, et al
    Rapid resolution of cytokine release syndrome and favorable clinical course of severe COVID-19 in a kidney transplant recipient treated with tocilizumab.
    Kidney Int. 2020 Jun 4. pii: S0085-2538(20)30622.

  10. KEMMNER S, Guba M, Schonermarck U, Stangl M, et al
    Cyclosporine as preferred calcineurin inhibitor in renal allograft recipients with COVID-19 infection.
    Kidney Int. 2020 Jun 4. pii: S0085-2538(20)30628.

  11. ELENBERG E, O'Mahony CA, Eldin KW
    Ruptured gallbladder in cystinosis renal transplant recipient.
    Kidney Int. 2020;97:1304.

  12. GOMEZ-ALDANA A, Tapias M, Rosselli D
    Opt-out in kidney transplantation rates: the Colombian experience.
    Kidney Int. 2020;97:1299.

    April 2020
  13. MEHTA RB, Tandukar S, Jorgensen D, Randhawa P, et al
    Early subclinical tubulitis and interstitial inflammation in kidney transplantation have adverse clinical implications.
    Kidney Int. 2020 Apr 25. pii: S0085-2538(20)30408.
    PubMed     Abstract available

  14. BANERJEE D, Popoola J, Shah S, Ster IC, et al
    COVID-19 infection in kidney transplant recipients.
    Kidney Int. 2020 Apr 9. pii: S0085-2538(20)30361.
    PubMed     Abstract available

  15. COATES PT, Wong G, Drueke T, Rovin B, et al
    Early experience with COVID-19 in kidney transplantation.
    Kidney Int. 2020 Apr 9. pii: S0085-2538(20)30362.

  16. ALBERICI F, Delbarba E, Manenti C, Econimo L, et al
    A single center observational study of the clinical characteristics and short-term outcome of 20 kidney transplant patients admitted for SARS-CoV2 pneumonia.
    Kidney Int. 2020 Apr 9. pii: S0085-2538(20)30365.
    PubMed     Abstract available

  17. ROSSI M, L'Imperio V, Garces J, Fogo AB, et al
    The Case | Acute kidney injury after liver and kidney transplantation.
    Kidney Int. 2020;97:813-814.

    February 2020
  18. DE KOK MJ, Schaapherder AF, Mensink JW, de Vries AP, et al
    A nationwide evaluation of deceased donor kidney transplantation indicates detrimental consequences of early graft loss.
    Kidney Int. 2020 Feb 29. pii: S0085-2538(20)30224.
    PubMed     Abstract available

  19. DANGI A, Yu S, Lee FT, Burnette M, et al
    Murine cytomegalovirus dissemination but not reactivation in donor-positive/recipient-negative allogeneic kidney transplantation can be effectively prevented by transplant immune tolerance.
    Kidney Int. 2020 Feb 21. pii: S0085-2538(20)30151.
    PubMed     Abstract available

  20. JACOBS SE, Kirou KA, Seshan SV, Walsh TJ, et al
    The Case | Knee pain and allograft dysfunction in a kidney transplant recipient.
    Kidney Int. 2020;97:429-430.

    January 2020
  21. ALLAM SR, Madhrira MM, Memon IA, Tessier J, et al
    Invasive mucormycosis in a renal transplant recipient.
    Kidney Int. 2020;97:216.

    Arteriovenous fistulas in patients with kidney transplantation.
    Kidney Int. 2020;97:20-21.

    December 2019
  23. KAGAN I, McDonald ML, Gritsch HA, Yabu JM, et al
    Kidney transplantation utilizing a horseshoe kidney.
    Kidney Int. 2019;96:1427.

    Prediabetes after kidney transplantation-a reason to worry?
    Kidney Int. 2019;96:1280-1282.
    PubMed     Abstract available

    November 2019
  25. SAPIR-PICHHADZE R, Zhang X, Ferradji A, Madbouly A, et al
    Epitopes as characterized by antibody-verified eplet mismatches determine risk of kidney transplant loss.
    Kidney Int. 2019 Nov 12. pii: S0085-2538(19)31132.
    PubMed     Abstract available

  26. LASTER M, Pereira RC, Salusky IB
    Unraveling the osteocyte in CKD-MBD post-renal transplantation.
    Kidney Int. 2019;96:1059-1061.
    PubMed     Abstract available

    October 2019
  27. BANE O, Hectors SJ, Gordic S, Kennedy P, et al
    Multiparametric magnetic resonance imaging shows promising results to assess renal transplant dysfunction with fibrosis.
    Kidney Int. 2019 Oct 30. pii: S0085-2538(19)31038.
    PubMed     Abstract available

    September 2019
  28. PEDERSEN MS, Muller M, Rulicke T, Leitner N, et al
    Lymphangiogenesis in a mouse model of renal transplant rejection extends life span of the recipients.
    Kidney Int. 2019 Sep 3. pii: S0085-2538(19)30843.
    PubMed     Abstract available

  29. Angel-Korman A, Stern L, Sarosiek S, et al. Long-term outcome of kidney transplantation in AL amyloidosis. Kidney Int. 2019;95:405-411.
    Kidney Int. 2019;96:796.

    August 2019
  30. PORRINI E, Diaz JM, Moreso F, Lauzurrica R, et al
    Prediabetes is a risk factor for cardiovascular disease following renal transplantation.
    Kidney Int. 2019 Aug 14. pii: S0085-2538(19)30810.
    PubMed     Abstract available

  31. DUPONT V, Colosio C, Hureaux M, Mokri L, et al
    The Case | Severe hypertension and hyperkalemia in a kidney transplant recipient.
    Kidney Int. 2019;96:529-530.

  32. PHILIP NM, Naranje P, Bagchi S, Das CJ, et al
    Multiple abscesses in a renal transplant recipient.
    Kidney Int. 2019;96:526.

    July 2019
  33. CHADBAN S, Tedesco-Silva H
    ATHENA: wisdom and warfare in defining the role of de novo mTOR inhibition in kidney transplantation.
    Kidney Int. 2019;96:27-30.
    PubMed     Abstract available

  34. KAUNDAL U, Ramachandran R, Arora A, Kenwar DB, et al
    B cells: a new player in mesenchymal stromal cell-mediated immune modulation in renal transplant patients.
    Kidney Int. 2019;96:249-250.

    June 2019
  35. ARAUJO MJCLN, Bacelar Marques ID, Graciolli FG, Fukuhara L, et al
    Comparison of serum levels with bone content and gene expression indicate a contradictory effect of kidney transplantation on sclerostin.
    Kidney Int. 2019 Jun 25. pii: S0085-2538(19)30626.
    PubMed     Abstract available

  36. RANGASWAMI J, Bangalore S, Kaplan B, Birdwell KA, et al
    Cardiovascular disease care fragmentation in kidney transplantation: a call for action.
    Kidney Int. 2019 Jun 10. pii: S0085-2538(19)30586.

    May 2019
  37. DRIOLLET B, Bayer F, Chatelet V, Macher MA, et al
    Social deprivation is associated with poor kidney transplantation outcome in children.
    Kidney Int. 2019 May 28. pii: S0085-2538(19)30530.
    PubMed     Abstract available

  38. LEE LOY J, Koratala A, De Los Santos Y, Chamarthi G, et al
    Disseminated toxoplasmosis: a life-threatening complication of inadequate posttransplant prophylaxis.
    Kidney Int. 2019;95:1274.

    April 2019
  39. FORMAN C, Sran H, Wafi A
    Delayed stricture of irradiated iliac arteries after renal transplantation mimicking transplant renal artery stenosis.
    Kidney Int. 2019;95:999.

  40. D'AMBROSIO R, Vinci M, Franchina M, Parlati L, et al
    Effectiveness and safety of sofosbuvir-based direct-acting antiviral combinations in HCV-2 and HCV-3 kidney transplant recipients.
    Kidney Int. 2019;95:993-995.

  41. BARBOUR S, Djurdjev O, Gill JS, Dong JJ, et al
    A propensity score matched analysis shows no adverse effect of early steroid withdrawal in non-diabetic kidney transplant recipients with and without glomerulonephritis.
    Kidney Int. 2019 Apr 1. pii: S0085-2538(19)30388.
    PubMed     Abstract available

    Evaluation of living donors: quo vadis for GFR criteria?
    Kidney Int. 2019;95:738-740.
    PubMed     Abstract available

  43. SINGH G, Swamy A, Kumari K, Brijwal M, et al
    The Case | Mass in nonfunctioning first renal allograft in a recipient of 2 transplant kidneys.
    Kidney Int. 2019;95:1001-1002.

  44. GAILLARD F, Courbebaisse M, Kamar N, Rostaing L, et al
    Impact of estimation versus direct measurement of predonation glomerular filtration rate on the eligibility of potential living kidney donors.
    Kidney Int. 2019;95:896-904.
    PubMed     Abstract available

  45. LEIBLER C, Thiolat A, Elsner RA, El Karoui K, et al
    Costimulatory blockade molecules and B-cell-mediated immune response: current knowledge and perspectives.
    Kidney Int. 2019;95:774-786.
    PubMed     Abstract available

    March 2019
  46. TAYLOR DM, Bradley JA, Bradley C, Draper H, et al
    Limited health literacy is associated with reduced access to kidney transplantation.
    Kidney Int. 2019 Mar 27. pii: S0085-2538(19)30049.
    PubMed     Abstract available

  47. CHERUKURI A, Mehta R, Sharma A, Sood P, et al
    Post-transplant donor specific antibody is associated with poor kidney transplant outcomes only when combined with both T-cell-mediated rejection and non-adherence.
    Kidney Int. 2019 Mar 20. pii: S0085-2538(19)30176.
    PubMed     Abstract available

  48. FU R, Kim SJ, de Oliveira C, Coyte PC, et al
    An instrumental variable approach quantifies and confirms the duration of pre-transplant dialysis has negative impact on kidney transplant recipient survival.
    Kidney Int. 2019 Mar 19. pii: S0085-2538(19)30323.
    PubMed     Abstract available

  49. LEFAUCHEUR C, Viglietti D, Bouatou Y, Philippe A, et al
    Non-HLA agonistic anti-angiotensin II type 1 receptor antibodies induce a distinctive phenotype of antibody-mediated rejection in kidney transplant recipients.
    Kidney Int. 2019 Mar 15. pii: S0085-2538(19)30173.
    PubMed     Abstract available

  50. OTTLEWSKI I, Munch J, Wagner T, Schonauer R, et al
    Value of renal gene panel diagnostics in adults waiting for kidney transplantation due to undetermined end-stage renal disease.
    Kidney Int. 2019 Mar 15. pii: S0085-2538(19)30187.
    PubMed     Abstract available

  51. SNANOUDJ R, Kamar N, Cassuto E, Caillard S, et al
    Epitope load identifies kidney transplant recipients at risk of allosensitization following minimization of immunosuppression.
    Kidney Int. 2019 Mar 5. pii: S0085-2538(19)30115.
    PubMed     Abstract available

  52. EVENEPOEL P, Claes K, Meijers B, Laurent MR, et al
    Bone mineral density, bone turnover markers, and incident fractures in de novo kidney transplant recipients.
    Kidney Int. 2019 Mar 4. pii: S0085-2538(19)30105.
    PubMed     Abstract available

  53. BRUNEL M, Leclerc-Mercier S, Barnier JP, Bille E, et al
    The Case | Posttransplant upper limb inflammatory nodules.
    Kidney Int. 2019;95:721-722.

  54. WANG F, Yang C, Long J, Zhao X, et al
    Executive summary for the 2015 Annual Data Report of the China Kidney Disease Network (CK-NET).
    Kidney Int. 2019;95:501-505.
    PubMed     Abstract available

  55. SRIVASTAVA P, Solanki AK, Arif E, Wolf BJ, et al
    Development of a novel cell-based assay to diagnose recurrent focal segmental glomerulosclerosis patients.
    Kidney Int. 2019;95:708-716.
    PubMed     Abstract available

  56. LI J, Koerner J, Basler M, Brunner T, et al
    Immunoproteasome inhibition induces plasma cell apoptosis and preserves kidney allografts by activating the unfolded protein response and suppressing plasma cell survival factors.
    Kidney Int. 2019;95:611-623.
    PubMed     Abstract available

    February 2019
  57. FRIBOURG M, Anderson L, Fischman C, Cantarelli C, et al
    T-cell exhaustion correlates with improved outcomes in kidney transplant recipients.
    Kidney Int. 2019 Feb 27. pii: S0085-2538(19)30192.
    PubMed     Abstract available

  58. SOMMERER C, Suwelack B, Dragun D, Schenker P, et al
    An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients.
    Kidney Int. 2019 Feb 27. pii: S0085-2538(19)30193.
    PubMed     Abstract available

  59. WEWERS TM, Mayer AB, Pfleiderer A, Beul K, et al
    Increased soluble fms-like tyrosine kinase 1 after ischemia reperfusion contributes to adverse clinical outcomes following kidney transplantation.
    Kidney Int. 2019 Feb 22. pii: S0085-2538(18)30901.
    PubMed     Abstract available

  60. NUVOLONE M, Merlini G
    Improved outcomes for kidney transplantation in AL amyloidosis: impact on practice.
    Kidney Int. 2019;95:258-260.
    PubMed     Abstract available

  61. SUMMERS DM, Pettigrew GJ
    Uncontrolled DCD donation-tilting at windmills or pushing against an open door?
    Kidney Int. 2019;95:263-265.
    PubMed     Abstract available

  62. YAGISAWA T, Tanaka T, Miyairi S, Tanabe K, et al
    In the absence of natural killer cell activation donor-specific antibody mediates chronic, but not acute, kidney allograft rejection.
    Kidney Int. 2019;95:350-362.
    PubMed     Abstract available

    January 2019
  63. SMITH SF, Hosgood SA, Nicholson ML
    Ischemia-reperfusion injury in renal transplantation: 3 key signaling pathways in tubular epithelial cells.
    Kidney Int. 2019;95:50-56.
    PubMed     Abstract available

  64. DOTIS J, Printza N, Stabouli S, Karava V, et al
    Disseminated mucormycosis in an adolescent kidney transplant recipient.
    Kidney Int. 2019;95:236.

  65. EVERSON L, Bernstein BS, Chatterjee D, Lindsey B, et al
    ThINK before living donor transplantation.
    Kidney Int. 2019;95:237.

  66. HALL IE, Akalin E, Bromberg JS, Doshi MD, et al
    Deceased-donor acute kidney injury is not associated with kidney allograft failure.
    Kidney Int. 2019;95:199-209.
    PubMed     Abstract available

    December 2018
  67. ANGEL-KORMAN A, Stern L, Sarosiek S, Sloan JM, et al
    Long-term outcome of kidney transplantation in AL amyloidosis.
    Kidney Int. 2018 Dec 20. pii: S0085-2538(18)30774.
    PubMed     Abstract available

  68. DEL RIO F, Andres A, Padilla M, Sanchez-Fructuoso AI, et al
    Kidney transplantation from donors after uncontrolled circulatory death: the Spanish experience.
    Kidney Int. 2018 Dec 19. pii: S0085-2538(18)30717.
    PubMed     Abstract available

  69. ERPICUM P, Weekers L, Detry O, Bonvoisin C, et al
    Infusion of third-party mesenchymal stromal cells after kidney transplantation: a phase I-II, open-label, clinical study.
    Kidney Int. 2018 Dec 6. pii: S0085-2538(18)30712.
    PubMed     Abstract available

  70. KOPP JB
    Expanding the spectrum of APOL1-related renal disease: de novo collapsing glomerulopathy following kidney transplant.
    Kidney Int. 2018;94:1048-1050.
    PubMed     Abstract available

  71. SAMPATHKUMAR K, Mukuntharajan T, Rajiv A, Anandan S, et al
    Acute page kidney phenomenon following renal allograft biopsy.
    Kidney Int. 2018;94:1241.

    November 2018
  72. JOHNSON SC, Martinez F, Bitto A, Gonzalez B, et al
    mTOR inhibitors may benefit kidney transplant recipients with mitochondrial diseases.
    Kidney Int. 2018 Nov 21. pii: S0085-2538(18)30645.
    PubMed     Abstract available

  73. YAZDANI S, Callemeyn J, Gazut S, Lerut E, et al
    Natural killer cell infiltration is discriminative for antibody-mediated rejection and predicts outcome after kidney transplantation.
    Kidney Int. 2018 Nov 2. pii: S0085-2538(18)30630.
    PubMed     Abstract available

  74. JARDINE AG, Hartmann A, Holdaas H
    Long-term renal allograft survival: a quiet revolution.
    Kidney Int. 2018;94:853-855.
    PubMed     Abstract available

    October 2018
  75. SANTORIELLO D, Husain SA, De Serres SA, Bomback AS, et al
    Donor APOL1 high-risk genotypes are associated with increased risk and inferior prognosis of de novo collapsing glomerulopathy in renal allografts.
    Kidney Int. 2018 Oct 2. pii: S0085-2538(18)30481.
    PubMed     Abstract available

  76. COZZI E, Biancone L
    C1q-binding donor-specific antibody assays help define risk and prognosis in antibody-mediated rejection.
    Kidney Int. 2018;94:657-659.
    PubMed     Abstract available

    September 2018
  77. CASPER J, Schmitz J, Brasen JH, Khalifa A, et al
    Renal transplant recipients receiving loop diuretic therapy have increased urinary tract infection rate and altered medullary macrophage polarization marker expression.
    Kidney Int. 2018 Sep 22. pii: S0085-2538(18)30516.
    PubMed     Abstract available

    August 2018
  78. FRANCIS A, Johnson DW, Craig J, Teixeira-Pinto A, et al
    Post-transplant lymphoproliferative disease may be an adverse risk factor for patient survival but not graft loss in kidney transplant recipients.
    Kidney Int. 2018 Aug 26. pii: S0085-2538(18)30446.
    PubMed     Abstract available

    July 2018
  79. COEMANS M, Susal C, Dohler B, Anglicheau D, et al
    Analyses of the short- and long-term graft survival after kidney transplantation in Europe between 1986 and 2015.
    Kidney Int. 2018 Jul 20. pii: S0085-2538(18)30392.
    PubMed     Abstract available

    June 2018
  80. LANDWEHR-KENZEL S, Zobel A, Hoffmann H, Landwehr N, et al
    Ex vivo expanded natural regulatory T cells from patients with end-stage renal disease or kidney transplantation are useful for autologous cell therapy.
    Kidney Int. 2018;93:1452-1464.
    PubMed     Abstract available

    May 2018
  81. KOPP JB
    Global glomerulosclerosis in primary nephrotic syndrome: including age as a variable to predict renal outcomes.
    Kidney Int. 2018;93:1043-1044.
    PubMed     Abstract available

  82. NADA R, Ramachandran R, Kumar A, Gupta KL, et al
    Tumoral masses in failed kidneys.
    Kidney Int. 2018;93:1253.

    April 2018
  83. SAID SM, Cosio FG, Valeri AM, Leung N, et al
    Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits is associated with high rate of early recurrence in the allograft.
    Kidney Int. 2018 Apr 28. pii: S0085-2538(18)30175.
    PubMed     Abstract available

  84. TANER T, Gustafson MP, Hansen MJ, Park WD, et al
    Donor-specific hypo-responsiveness occurs in simultaneous liver-kidney transplant recipients after the first year.
    Kidney Int. 2018 Apr 12. pii: S0085-2538(18)30135.
    PubMed     Abstract available

    March 2018
  85. BATAL I, Mohan S, De Serres SA, Vasilescu ER, et al
    Analysis of dendritic cells and ischemia-reperfusion changes in postimplantation renal allograft biopsies may serve as predictors of subsequent rejection episodes.
    Kidney Int. 2018 Mar 13. pii: S0085-2538(18)30059.
    PubMed     Abstract available

  86. GREENLEAF E, Farooq U, Jain A, DiCristina R, et al
    Native kidney pyelonephritis as the cause of recurrent urinary tract infections in a kidney transplant recipient.
    Kidney Int. 2018;93:762.

  87. SIVAYOGANATHAN S, Ariyawansa D, Ambawatte P, Galahitiyawa C, et al
    A rare presentation of a posttransplant lymphoproliferative disorder.
    Kidney Int. 2018;93:761.

    February 2018
  88. DURAND M, Dubois F, Dejou C, Durand E, et al
    Increased degradation of ATP is driven by memory regulatory T cells in kidney transplantation tolerance.
    Kidney Int. 2018 Feb 15. pii: S0085-2538(18)30001.
    PubMed     Abstract available

  89. REICH B, Viehmann SF, Kurts C
    Plasmacytoid dendritic cells: important players in human kidney allograft rejection.
    Kidney Int. 2018;93:301-303.
    PubMed     Abstract available

  90. RUBEN JM, Garcia-Romo GS, Breman E, van der Kooij S, et al
    Human plasmacytoid dendritic cells acquire phagocytic capacity by TLR9 ligation in the presence of soluble factors produced by renal epithelial cells.
    Kidney Int. 2018;93:355-364.
    PubMed     Abstract available

  91. HEIDT S, Haasnoot GW, van Rood JJ, Witvliet MD, et al
    Kidney allocation based on proven acceptable antigens results in superior graft survival in highly sensitized patients.
    Kidney Int. 2018;93:491-500.
    PubMed     Abstract available

    January 2018
  92. CHUTE DF, Chung RT, Sise ME
    Direct-acting antiviral therapy for hepatitis C virus infection in the kidney transplant recipient.
    Kidney Int. 2018 Jan 9. pii: S0085-2538(17)30807.
    PubMed     Abstract available

  93. RODELO-HAAD C, Aguera ML, Ortega R, Martinez-Lopez A, et al
    Lithium-associated nephropathy in the renal allograft.
    Kidney Int. 2018;93:273.

  94. ETTA PK, Rao MV
    Gas in a renal allograft: think beyond!
    Kidney Int. 2018;93:272.

    December 2017
  95. LI J, Basler M, Alvarez G, Brunner T, et al
    Immunoproteasome inhibition prevents chronic antibody-mediated allograft rejection in renal transplantation.
    Kidney Int. 2017 Dec 4. pii: S0085-2538(17)30773.
    PubMed     Abstract available

    October 2017
  96. LIM WH, Wong G, Heidt S, Claas FHJ, et al
    Novel aspects of epitope matching and practical application in kidney transplantation.
    Kidney Int. 2017 Oct 20. pii: S0085-2538(17)30604.
    PubMed     Abstract available

    September 2017
  97. YACOUB R, Nadkarni GN, Cravedi P, He JC, et al
    Analysis of OPTN/UNOS registry suggests the number of HLA matches and not mismatches is a stronger independent predictor of kidney transplant survival.
    Kidney Int. 2017 Sep 28. pii: S0085-2538(17)30547.
    PubMed     Abstract available

  98. PEARL MH, Zhang Q, Palma Diaz MF, Grotts J, et al
    Angiotensin II Type 1 receptor antibodies are associated with inflammatory cytokines and poor clinical outcomes in pediatric kidney transplantation.
    Kidney Int. 2017 Sep 16. pii: S0085-2538(17)30509.
    PubMed     Abstract available

  99. MENGEL M
    Deconstructing interstitial fibrosis and tubular atrophy: a step toward precision medicine in renal transplantation.
    Kidney Int. 2017;92:553-555.
    PubMed     Abstract available

    August 2017
    Recurrence of glomerulonephritis: an underestimated and unmet medical need.
    Kidney Int. 2017;92:294-296.
    PubMed     Abstract available

    July 2017
  101. BROCKLEBANK V, Johnson S, Sheerin TP, Marks SD, et al
    Factor H autoantibody is associated with atypical hemolytic uremic syndrome in children in the United Kingdom and Ireland.
    Kidney Int. 2017 Jul 24. pii: S0085-2538(17)30323.
    PubMed     Abstract available

  102. KENTRUP D, Bovenkamp P, Busch A, Schuette-Nuetgen K, et al
    GlucoCEST magnetic resonance imaging in vivo may be diagnostic of acute renal allograft rejection.
    Kidney Int. 2017 Jul 11. pii: S0085-2538(17)30303.
    PubMed     Abstract available

    June 2017
  103. ALLEN PJ, Chadban SJ, Craig JC, Lim WH, et al
    Recurrent glomerulonephritis after kidney transplantation: risk factors and allograft outcomes.
    Kidney Int. 2017 Jun 7. pii: S0085-2538(17)30208.
    PubMed     Abstract available

  104. CLAYTON PA, Coates PT
    Are sensitized patients better off with a desensitization transplant or waiting on dialysis?
    Kidney Int. 2017;91:1266-1268.
    PubMed     Abstract available

    May 2017
  105. HAAS M
    Simultaneous liver-kidney transplantation: shifting renal allograft gene expression from inflammation toward preservation.
    Kidney Int. 2017;91:1010-1013.
    PubMed     Abstract available

  106. MJOEN G, Holdaas H
    Regarding "Obesity increases the risk of end-stage renal disease among living kidney donors".
    Kidney Int. 2017;91:1256.

    April 2017
  107. GILL J, Rose C, Joffres Y, Kadatz M, et al
    Cold ischemia time up to 16 hours has little impact on living donor kidney transplant outcomes in the era of kidney paired donation.
    Kidney Int. 2017 Apr 19. pii: S0085-2538(17)30105.
    PubMed     Abstract available

  108. SCHAUERTE C, Hubner A, Rong S, Wang S, et al
    Antagonism of profibrotic microRNA-21 improves outcome of murine chronic renal allograft dysfunction.
    Kidney Int. 2017 Apr 8. pii: S0085-2538(17)30117.
    PubMed     Abstract available

  109. NADKARNI GN, Wyatt CM, Murphy B, Ross MJ, et al
    APOL1: a case in point for replacing race with genetics.
    Kidney Int. 2017;91:768-770.
    PubMed     Abstract available

  110. WIJKSTROM M, Iwase H, Paris W, Hara H, et al
    Renal xenotransplantation: experimental progress and clinical prospects.
    Kidney Int. 2017;91:790-796.
    PubMed     Abstract available

    March 2017
  111. LAM NN, Tonelli M, Lentine KL, Hemmelgarn B, et al
    Albuminuria and posttransplant chronic kidney disease stage predict transplant outcomes.
    Kidney Int. 2017 Mar 30. pii: S0085-2538(17)30093.
    PubMed     Abstract available

  112. BRASEN JH, Khalifa A, Schmitz J, Dai W, et al
    Macrophage density in early surveillance biopsies predicts future renal transplant function.
    Kidney Int. 2017 Mar 27. pii: S0085-2538(17)30094.
    PubMed     Abstract available

  113. SICARD A, Meas-Yedid V, Rabeyrin M, Koenig A, et al
    Computer-assisted topological analysis of renal allograft inflammation adds to risk evaluation at diagnosis of humoral rejection.
    Kidney Int. 2017 Mar 15. pii: S0085-2538(17)30038.
    PubMed     Abstract available

  114. RAVINDRAN A, Go RS, Fervenza FC, Sethi S, et al
    Thrombotic microangiopathy associated with monoclonal gammopathy.
    Kidney Int. 2017;91:691-698.
    PubMed     Abstract available

    February 2017
  115. SHIU KY, McLaughlin L, Rebollo-Mesa I, Zhao J, et al
    Graft dysfunction in chronic antibody-mediated rejection correlates with B-cell-dependent indirect antidonor alloresponses and autocrine regulation of interferon-gamma production by Th1 cells.
    Kidney Int. 2017;91:477-492.
    PubMed     Abstract available

    January 2017
  116. HAAS M, Mirocha J, Reinsmoen NL, Vo AA, et al
    Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent/recurrent versus de novo donor-specific antibodies.
    Kidney Int. 2017 Jan 16. pii: S0085-2538(16)30656.
    PubMed     Abstract available

    December 2016
  117. LOCKE JE, Reed RD, Massie A, MacLennan PA, et al
    Obesity increases the risk of end-stage renal disease among living kidney donors.
    Kidney Int. 2016 Dec 29. pii: S0085-2538(16)30613.
    PubMed     Abstract available

  118. LITJENS NH, Boer K, Zuijderwijk JM, Klepper M, et al
    Natural regulatory T cells from patients with end-stage renal disease can be used for large-scale generation of highly suppressive alloantigen-specific Tregs.
    Kidney Int. 2016 Dec 14. pii: S0085-2538(16)30599.
    PubMed     Abstract available

    October 2016
  119. CHERUKURI A, Salama AD, Carter CR, Landsittel D, et al
    Reduced human transitional B cell T1/T2 ratio is associated with subsequent deterioration in renal allograft function.
    Kidney Int. 2016 Oct 28. pii: S0085-2538(16)30481.
    PubMed     Abstract available

    August 2016
  120. BIENAIME F, Legendre C, Terzi F, Canaud G, et al
    Antiphospholipid syndrome and kidney disease.
    Kidney Int. 2016 Aug 20. pii: S0085-2538(16)30317.
    PubMed     Abstract available

    June 2016
  121. CHEN T, Cleland B, Nankivell BJ
    The Case | Rapidly progressing polyneuropathy in a dialysis patient.
    Kidney Int. 2016;89:1409-10.

    May 2016
  122. DRAGUN D, Catar R, Philippe A
    Non-HLA antibodies against endothelial targets bridging allo- and autoimmunity.
    Kidney Int. 2016 May 14. pii: S0085-2538(16)30071.
    PubMed     Abstract available

  123. ROMANOWSKI K, Clark EG, Levin A, Cook VJ, et al
    Tuberculosis and chronic kidney disease: an emerging global syndemic.
    Kidney Int. 2016 May 10. pii: S0085-2538(16)30053.
    PubMed     Abstract available

  124. MA L, Langefeld CD, Comeau ME, Bonomo JA, et al
    APOL1 renal-risk genotypes associate with longer hemodialysis survival in prevalent nondiabetic African American patients with end-stage renal disease.
    Kidney Int. 2016 May 5. pii: S0085-2538(16)30012.
    PubMed     Abstract available

    April 2016
  125. ZHANG L, Lee G, Liu X, Pascoe EM, et al
    Long-term outcomes of end-stage kidney disease for patients with lupus nephritis.
    Kidney Int. 2016 Apr 8. pii: S0085-2538(16)00363.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Kidney Transplantation is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.